New ALS drug stabilizes decline with a trend toward impro
Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS by Julia Evangelou Strait•December 22, 2025 Huy Mach Rickey Malloy (left), who receives tofersen treatment for SOD1-ALS at WashU Medicine, plays a round of golf with his wife, Jenny, and their son, Kash. Long-term […]
New ALS drug stabilizes decline with a trend toward impro Read More »
